Adverse reactions to rifabutin.
Kaipiainen-Seppänen
O
O
Hyvärinen
L
L
D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D001168:Arthritis / Q000139:chemically induced* / Q000473:pathology; D017291:Clarithromycin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy; D009170:Nontuberculous Mycobacteria / Q000302:isolation & purification / Q000472:pathogenicity; D017828:Rifabutin / Q000009:adverse effects*; D014606:Uveitis, Anterior / Q000139:chemically induced* / Q000473:pathology
D000900:Anti-Bacterial Agents; D017828:Rifabutin; D004977:Ethambutol; D017291:Clarithromycin